Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1Polycystic Kidney, Autosomal Dominant 1Hypertension 1Hematologic Neoplasms 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

pertuzumab 3trametinib 2palbociclib 2dabrafenib 2copanlisib 2Trastuzumab 2Sunitinib 2Specimen Handling 2Sorafenib 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Immunoglobulin G 2HhAntag691 2Fluorouracil 2Disulfides 2Dasatinib 2Bevacizumab 2Afatinib 2Ado-Trastuzumab Emtansine 22C4 antibody 2venetoclax 1ulixertinib 1trastuzumab biosimilar HLX02 1temsirolimus 1sapanisertib 1ruxolitinib 1romidepsin 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Polymorphism, Genetic × Genitourinary × Clear all
NCT06416761 2024-05-16

Genetics in the Progression of Nephropathies

Ospedale San Raffaele

Recruiting
10,000 enrolled
GenitourinaryOther hematologic neoplasm

Hypertension, Chronic Kidney Disease-Mineral and Bone Disorder, Polycystic Kidney, Autosomal Dominant, Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡